Loading...
Akoya Biosciences reported a strong financial performance in Q2 2023, achieving record revenue of $23.5 million, a 31% increase year-over-year. The company highlighted its leading position in spatial biology and its focus on moving towards profitability.
Total revenue reached $23.5 million, a 31% increase compared to the prior year period.
Product revenue (instruments, reagents, and software) increased by 20% to $17.1 million.
Service and other revenue grew significantly by 73% to $6.4 million.
Gross profit was $12.1 million with a gross profit margin of 51.5%.
The company continues to expect full year 2023 revenue in the range of $95-98 million.
Visualization of income flow from segment revenue to net income